Company intelligence / Profile preview

Progenitor Holdings

Switzerland

Ownership: Private
Development stage: Other

Overview

Progenitor Holdings was a European-headquartered emerging market clinical research organization that conducted international drug development services. The organization was involved in over 70 vaccine and infectious disease trials with over 50,000 patients recruited in recent years prior to acquisition.

Therapeutic areas: OtherInfectious Diseases
Industry: Contract Research Organization

Beyond the preview

Go deeper on Progenitor Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Progenitor Holdings.

Explore the full profile